Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 127 results for "glaxosmithkline consumer healthcare"

GSK Consumer Healthcare Q2 profit up 37%

Ahlquist v. GlaxoSmithKline Consumer Healthcare: pre-certifica...

The recent decision of Ahlquist v. GlaxoSmithKline Consumer Healthcare, 2015 SKQB 192 , concerns the scope of pre-certification disclosure in class actions. Ahlquist involved denture adhesives manufactured by GlaxoSmithKline Consumer Healthcare ... Lexology, 1 week ago

Price Target Update on GlaxoSmithKline PLC (NYSE:GSK)

GlaxoSmithKline PLC (NYSE:GSK) shares are expected to touch $48.5 in the short term. This short term price target has been shared by 2 analysts. However, the standard deviation of short term price estimate has been valued at 4.95. The target price ...
 MoneyFlowIndex.org6 days ago Analyst Price Target Update on GlaxoSmithKline PLC (NYSE:GSK)  MoneyFlowIndex.org1 month ago

M Pharmaceutical signs LOI to buy reformulated orlistat for weight loss from Chelatexx

M Pharmaceutical has entered into a letter of intent (LOI) to acquire assets from Chelatexx related to a reformulated version of orlistat (product "C-103"). The addition of C-103 provides a novel weight loss pharmaceutical product to the M Pharma ...
 Pharmaceutical Business Review1 day ago REPEAT: M Pharmaceutical Enters Into Letter of Intent to Acquire Reformulated Orlistat for Weight Loss from Chelatexx, LLC  Pharmacy Choice2 days ago M Pharmaceutical to acquire C-103 from Chelatexx  Stockwatch5 days ago M Pharmaceutical Enters Into Letter of Intent to Acquire Reformulated Orlistat for Weight Loss from Chelatexx, LLC  Bloomberg5 days ago

M Pharmaceutical Inc. (MPHMF: OTCQB) | M Pharmaceutical Enters Into Letter of Intent to Acquire Reformulated Orlistat for Weight Loss from Chelatexx, LLC

- C-103 is a patented reformulation of FDA-approved orlistat (Xenical(R) and alli(R)) - Chelatexx asset acquisition part of a comprehensive reorganization of M Pharmaceutical to focus its efforts on development of oral products for obesity ...
 OTC Markets5 days ago

Making the most of a smart office

Open-office plans, more meeting rooms and fewer cabins—new office spaces could encourage teams to engage with each other in a more cohesive manner Cities are not the only urban entities aspiring to become smarter—offices are looking at this ...
 Livemint.com3 days ago

Every fall in market is an opportunity to value-pick

NEW DELHI: Even though the bull market argument is still intact, the temporary bear phase that the market is going through is also creating opportunity for investors to generate wealth, as most of the good quality stocks have corrected ...
 Economic Times1 week ago

GSK Consumer Healthcare names U.S. VP of sales

Supplier News Breaks October 26th, 2015 PARSIPPANY, N.J. Procter & Gamble veteran Dennis Curran has joined GlaxoSmithKline Consumer Healthcare as U.S. vice president of sales and chief customer officer. GSK Consumer Healthcare said Friday ...
 Mass Market Retailers2 weeks ago

GlaxoSmithkline Q2 net profit surges 36.85 percent

GlaxoSmithkline Consumer Healthcare on Friday reported an increase of 36.85 percent in its net profit for the quarter ended September 30 this year, at Rs.219.37 crore as against Rs.160.29 crore in the corresponding quarter of 2014-15. Its net ...
 ProKerala.com2 weeks ago

GLAXOSMITHKLINE PAKISTAN : Extraordinary general meeting of GlaxoSmithKline Pakistan Limited

GlaxoSmithKline Pakistan Limited informed Karachi Stock Exchange that Extraordinary general meeting of the company shall be held on November 30, 2015 at Karachi. The agenda of the meeting will be to consider and if thought fit to pass with or ...
 4 Traders2 weeks ago

GlaxoSmithKline (GSK) Announces Quarterly Earnings Results, Beats Expectations By $0.04 EPS

GlaxoSmithKline (GSK) announced its quarterly earnings results on Wednesday, Oct-28-2015. The company reported $0.23 Earnings Per Share for the quarter, beating the analyst consensus estimate by $0.04. Analyst had a consensus of $0.19 EPS. The ...
 MoneyFlowIndex.org4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glaxosmithkline consumer healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less